It took twelve years for the FDA to approve mifepristone--also known as RU-486--and most of that time had less to do with medicine than with the politics of abortion. Still, the late-September decision was a tremendous victory for American women. In approving RU-486, the FDA showed that science and good sense can still carry the day, even in an election year.

The long delay may even backfire against the drug's opponents. In 1988, when mifepristone was legalized in France, it was a medical novelty as well as a political flashpoint. Today, it's been accepted in thirteen countries, including most of Western Europe; it's been taken by more than a half-million women and studied, it sometimes seems, by almost as many researchers. By the end of the approval process, the important medical professional organizations--the AMA, the American Medical Women's Association, the American College of Obstetricians and Gynecologists--had given mifepristone their blessing; impressive percentages of Ob-Gyns and family practitioners said they would consider prescribing it; thousands of US women had taken it in clinical trials and given it high marks, with 97 percent in one study saying they would recommend it to a friend. Against this background of information and experience, the antichoicers' attempt to raise fears about the drug's safety sounds desperate and insincere.

In a normal country, RU-486 would simply be another abortion method, its use a matter of personal preference (in France it's the choice of 20 percent of women who have abortions, while in Britain only 6 percent opt for it). But in the United States, where abortion clinics are besieged by fanatics and providers wear bulletproof vests, mifepristone's main significance lies in its potential to widen access to abortion, especially in those 86 percent of US counties that possess no abortion clinic, by making it private--doctors unable or unwilling to perform surgical abortions could prescribe it, and women could take it at home.

Subscriber Login

User Name

Password

Subscribe Now!

The only way to read this article and the full contents of each week's issue of The Nation online is by subscribing to the magazine. Subscribe now and read this article -- and every article published since for the past five years -- right now.

There's no obligation -- try The Nation for four weeks free.

• Get The Nation at home (and online!) for 75 cents a week!
• If you like this article, consider making a donation to The Nation.